Another Win in the Books
Let’s start this week with some good news! Dynavax Technologies Corporation (DVAX) completed its merger with French pharmaceutical giant Sanofi (SNY) a little over a week ago. Sanofi paid $15.50 per share in cash. So if you owned Dynavax, you should have already received the cash in your brokerage account. We’re walking away with a gain of a little over 39%.
Read More